Hermodsson; Svante

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hermodsson; Svante.The latest application filed is for "use of parp-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis".

Company Profile

0.3.10

Hermodsson; Svante - Molndal SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of PARP-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis App 20060079510 - Hellstrand; Kristoffer ; et al.	2006-04-13
Synergistic tumorcidal response induced by histamine App 20040219153 - Gehlsen, Kurt R. ; et al.	2004-11-04
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage App 20040191239 - Hellstrand, Kristoffer ; et al.	2004-09-30
Reactive oxygen metabolite inhibitors for use in compositions and methods of treatment App 20040120926 - Hellstrand, Kristoffer ; et al.	2004-06-24
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage Grant 6,730,692 - Hellstrand , et al. May 4, 2	2004-05-04
Elevation of circulating blood histamine levels Grant 6,613,788 - Hellstrand , et al. September 2, 2	2003-09-02
Activation and protection of T-cells (CD4+ and CD8+) using an H2 receptor agonist and other T-cell activating agents App 20030039628 - Hellstrand, Kristoffer ; et al.	2003-02-27
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage App 20030017145 - Hellstrand, Kristoffer ; et al.	2003-01-23
Synergistic tumorcidal response induced by histamine App 20020193416 - Gehlsen, Kurt R. ; et al.	2002-12-19
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage App 20020150565 - Hellstrand, Kristoffer ; et al.	2002-10-17
Method for treatment of cancer and infectious disease App 20020035998 - Hellstrand, Kristoffer ; et al.	2002-03-28
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage App 20010023256 - Hellstrand, Kristoffer ; et al.	2001-09-20
Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activity Grant 5,728,378 - Hellstrand , et al. March 17, 1	1998-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.